HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Orexin B |
|---|---|
| CAS number | 205640-91-1 |
| Class | Neuro & other |
| Molecular formula | C123H212N44O35S |
| Molecular weight | 2899.34 g/mol (PubChem 2899.3; ChemicalBook 2899.34) |
| Sequence | RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 (H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2; human, C-terminally amidated, 28 residues) |
| Form | Lyophilized powder, sterile glass vial |
| Purity target | ≥ 98% by HPLC |
| Vial formats | 5mg / 10mg |
| Documentation | COA + HPLC + MS, batch lot file where available |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C, protected from light and moisture; stable for extended periods when sealed. After reconstitution, hold at 2-8°C for short-term research use or aliquot and freeze at -20°C for longer storage, and minimize freeze-thaw cycles. For laboratory research use only. |
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 50 vials | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Orexin B (Hypocretin-2) is a 28-amino-acid, C-terminally amidated hypothalamic neuropeptide that signals preferentially through the OX2 receptor, supplied as a research-use reference peptide for B2B and private-label buyers.
Documentation
COA / HPLC / MS document support where available. Distribution scope confirmed before invoicing.
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Mass spectrometry identity confirmation against the Orexin B reference profile.
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Orexin B is supplied as a lyophilized (freeze-dried) powder in sealed vials at 5 mg and 10 mg fill weights. Custom fill weights and bulk quantities are available on RFQ. Material is intended strictly for laboratory research use.
Each lot ships with a Certificate of Analysis reporting identity and purity by RP-HPLC (typically ≥98%) together with mass-spectrometry confirmation of molecular weight. Supporting data such as amino-acid analysis, water/acetate content, or residual solvent testing can be provided on request.
Our standard product is human Orexin B (Hypocretin-2), a 28-residue C-terminally amidated peptide: CAS 205640-91-1, molecular formula C123H212N44O35S, MW approximately 2899.4 g/mol, sequence RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2. Rat/mouse sequence variants can be quoted separately on request.
Standard MOQ is 50 vials. We provide private-label and OEM services including custom labeling, kitting, and lot documentation; larger volume tiers and contract-manufacturing terms are quoted on RFQ.
Yes. Orexin B is offered exclusively as a research-use reference material for laboratory and manufacturing customers. It is not a drug, food, cosmetic, or dietary supplement and is not supplied for human or veterinary use. Buyers are responsible for compliance with applicable regulations in their destination market.
Related compounds